Danish pharma major Novo Nordisk and privately-held Californian firm Deep Apple Therapeutics have announced a research ...

Insmed earlier announced positive top-line results from its randomized, double-blind, placebo-controlled Phase IIb study of ...

The UK’s medicines regulator has released a suite of new guidelines to steer companies through its upcoming decentralized ...

US clinical-stage biotech Oncolytics Biotech today announced the appointment of Jared Kelly as chief executive (CEO) and a ...

The UK government has doubled the rate that pharma companies must repay on the sales of newer products to the National Health ...

South Korean biotech AriBio Co, specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of ...

Italian family-owned drugmaker Chiesi Group and Sweden’s Key2Brain today announced a worldwide license agreement to advance ...

Angelini Ventures has joined a syndicate of European life sciences investors to back Elkedonia, a French biotech developing a ...

China-based biotech Innogen is making a strategic pivot toward international visibility following regulatory clearance of its ...

Germany-based Arvato and Dutch immunology specialist argenx (Euronext: ARGX) have successfully achieved two important ...

Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...

Belgian drugmaker UCB (Euronext: UCB) today announced new three-year data from Phase III trials, and their open-label ...